End Your Chronic Pain Today With Nyloxin The Worlds Leading Neck and Shoulder Pain Relief Remedy

 
 
 
Nyloxin Product Overview

Pain Relief for Chronic Arthritis and Joint Pain

Nyloxin provides all-natural anti-inflammatory analgesic pain relief that is non-toxic, non-narcotic, non-addictive, non-steroidal and contains no aspirin or acetaminophen. Safe to use without a prescription, it treats conditions that cause chronic pain, including lower back pain, rheumatoid arthritis and other joint pain, headaches and migraines, neck pain, neuralgia, repetitive stress pain and more.

Nyloxin is 100% Safe to Treat Chronic Arthritis and Joint Pain

Nyloxin is believed to work by targeting some of the same receptors on nerve cells that are also recognized by nicotine. These receptors are found in nerves outside the central nervous system (brain and spinal cord) and they are also found on cells of the immune system. Specialized proteins in Nyloxin block the action of acetylcholine, a major stimulating neurotransmitter in the nervous system and activator of the inflammatory pathways. As a result, the pain and inflammation pathways are temporarily shut off. In some clinical studies, Nyloxin pain relieving products could provide prolonged chronic muscle and joint relief.

Nyloxin in American Medicine

The medical application of cobra venom was incorporated into the Materia Medica in the 1800s along with several other snake venoms. In the early 1900s, Calmette (of BCG fame) investigated the use of cobra venom in the treatment of cancer in mice. It was subsequently applied clinically to subjects with cancer where it established a reputation in France for relieving pain. In 1936, Macht, a researcher within the pharmaceutical company, Westcott, Hynson and Dunning, showed that cobra venom, when injected in minute doses, produced analgesic effects that were superior to morphine in activity. In fact, cobra venom was employed when morphine was no longer effective or when patients became addicted to the opiate. Cobra venom proved to be 80% effective in the clinic for the treatment of headache and arthritis pain and it allowed long-term control of chronic pain conditions without addictive problems. A feature of this venom product was its slow onset of analgesic activity however its activity is prolonged. In 1938, acceptance of homeopathic medicine including cobra venom was incorporated into the Food, Drug & Cosmetic Act sponsored by Royal Copeland. In the latter part of the last century cobra venoms were studied for the treatment of severe pain but also rheumatism, trigeminal neuralgia, asthma, ocular therapy, and neuroses.